0001415889-24-004105.txt : 20240216 0001415889-24-004105.hdr.sgml : 20240216 20240216161051 ACCESSION NUMBER: 0001415889-24-004105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240214 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kapur Anil CENTRAL INDEX KEY: 0001730703 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20859 FILM NUMBER: 24648440 MAIL ADDRESS: STREET 1: 275 MADISON AVE STREET 2: SUITE 702 CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GERON CORP CENTRAL INDEX KEY: 0000886744 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 752287752 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 919 EAST HILLSDALE BOULEVARD STREET 2: SUITE 250 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6504737700 MAIL ADDRESS: STREET 1: 919 EAST HILLSDALE BOULEVARD STREET 2: SUITE 250 CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GERON CORPORATION DATE OF NAME CHANGE: 19960521 4 1 form4-02162024_090237.xml X0508 4 2024-02-14 0000886744 GERON CORP GERN 0001730703 Kapur Anil C/O GERON CORPORATION 919 EAST HILLSDALE BOULEVARD, SUITE 250 FOSTER CITY CA 94404 false true false false EVP, CORP STRATEGY & CCO 0 Employee Stock Option (Right to Buy) 2.10 2024-02-14 4 A 0 750000 0 A 2034-02-13 Common Stock 750000 750000 D This option vests in a series of 48 consecutive equal monthly installments commencing February 14, 2024, provided the optionee continues to provide service to the Company. /s/ Scott A. Samuels, attorney-in-fact 2024-02-16 EX-24 2 ex24-02162024_090238.htm ex24-02162024_090238.htm

POWER OF ATTORNEY


Know all by these presents, that the undersigned hereby constitutes and appoints each of Scott Samuels, Pamela Smith, Christopher Johnson, Laura Reederson, Angela Kantere, David Clark, Michelle Robertson, and Katherine Harmon, as well as Marina Remennik and Samuel Paullin of Cooley LLP, and each of them, the undersigned’s true and lawful attorney-in-fact to:


(1)

Prepare and execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer, director or beneficial owner of more than 10% of a registered class of securities of Geron Corporation (the “Company”), Form ID and Forms 3, 4, and 5 (including amendments thereto and joint filing agreements in connection therewith) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended and the rules thereunder;


(2)

do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form ID and Forms 3, 4, or 5, and execute any amendment or amendments thereto and joint filing agreements in connection therewith, and file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and


(3)

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.


The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.


This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the undersigned is no longer required to file Form ID or Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, (b) revocation by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in-fact or (c) as to any attorneys-in-fact individually, until such attorney-in-fact is no longer employed by the Company.


IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 21st day of September 2023.


Signature: /s/ Anil Kapur

Name: Anil Kapur